Brief: Alpine Immune Sciences Q2 EPS USD -0.27
14/08/2023 21:15
Aug 14 (Reuters) - Alpine Immune Sciences Q2 operating expenses USD 24.248 million. * Q2 income from operations USD -15.655 million * Q2 net income USD -13.156 million * Q2 collaboration revenue USD 8.593 million
Recent news on Alpine Immune Sciences
See all newsAlpine Immune Sciences Inc reports results for the quarter ended in January - Earnings Summary
Brief: Alpine Immune Sciences Q1 EPS USD -0.28 Vs. IBES Estimate USD -0.41
Moves: Lazard hires veteran healthcare dealmaker Colocci as vice chairman
U.S. RESEARCH ROUNDUP-Cheesecake Factory, Netflix, Texas Roadhouse
US STOCKS-S&P 500, Nasdaq end sharply higher on soft inflation data, eyes on earnings